Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Heading back to the trough (levels of biologics in IBD).
Peptide model of a highly conserved, N-terminal domain of apolipoprotein E is able to modulate lipoprotein binding to a member of the class A scavenger receptor family.
Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Heading back to the trough (levels of biologics in IBD).
Heading back to the trough (levels of biologics in IBD). Clin Gastroenterol Hepatol. 2015 Mar; 13(3):548-51.
View in:
PubMed
subject areas
Anti-Inflammatory Agents
Biological Products
Drug Therapy, Combination
Humans
Immunologic Factors
Inflammatory Bowel Diseases
Serum
Treatment Outcome
authors with profiles
Stephen B. Hanauer